Login / Signup

Dorsal root ganglion stimulation for the treatment of chronic pelvic pain: A systematic review.

Joe H GhorayebAhish ChitneniAdam RuppAnishinder ParkashAlaa Abd-Elsayed
Published in: Pain practice : the official journal of World Institute of Pain (2023)
Dorsal root ganglion stimulation for CPP continues to lack supportive evidence from well-designed, high-quality studies and recommendations from consensus committee experts. However, we present consistent evidence from level IV studies showing success with the use of DRGS for CPP in reducing pain symptoms along with reports of improved QOL through periods as short as 2 months to as long as 3 years. Because the available studies at this time are of low quality with a high risk of bias, we strongly recommend the facilitation of high-quality studies with larger sample sizes in order to better ascertain the utility of DRGS for this specific patient population. At the same time, from a clinical perspective, it may be reasonable and appropriate to evaluate patients for DRGS candidacy on a case-by-case basis, especially those patients who report CPP symptoms that are refractory to noninterventional measures and who may not be ideal candidates for other forms of neuromodulation.
Keyphrases
  • neuropathic pain
  • case control
  • spinal cord
  • chronic pain
  • end stage renal disease
  • pain management
  • newly diagnosed
  • ejection fraction
  • sleep quality
  • prognostic factors
  • adverse drug
  • electronic health record